Pee power: new sensor tracks chemo effects in real time
NCT ID NCT01693861
First seen Jan 06, 2026 · Last updated May 02, 2026 · Updated 15 times
Summary
This study tested a new, non-invasive way to monitor chemotherapy in people with advanced colorectal cancer. Researchers used special sensors to measure chemicals called nucleosides in patients' urine before and after treatment. The goal was to see if these urine levels could show how well the chemotherapy was working, without needing frequent blood tests or scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Paul Brousse Hospital
Villejuif, 94807, France
Conditions
Explore the condition pages connected to this study.